Skip to main contentSkip to navigation
Sirius Investors
Generex Biotechnology Corporation

Generex Biotechnology Corporation

GNBT
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for GNBT. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
4.09M
45.8x increase over period
CAGR: +17.27%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
15.31M
171.5x increase over period
CAGR: +23.89%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Apr 30, 2021

EV/EBITDA

Potentially Cheap

1.43x

Lower EV/EBITDA can indicate attractive valuation relative to operating earnings.

EV vs Market Cap Spread

11.22M

EV is +274.0% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +274.0 pp vs earliest data

Additional Multiples

EV/Sales: 678.00x

Net Debt/EBITDA: 0.78x

Share count change in dataset: +146126.00%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Jul 31, 20204.09M15.31M$0.0673.11M
Jul 31, 20193.79M11.88M$0.0667.70M
Jul 31, 20183.02M16.16M$0.0653.99M
Jul 31, 2017
Jul 31, 2016
Jul 31, 2015
Jul 31, 2014
Jul 31, 2013
Jul 31, 2012
Jul 31, 2011
Jul 31, 2010
Jul 31, 2009
Jul 31, 2008
Jul 31, 2007
Jul 31, 2006
Jul 31, 2005
Jul 31, 2004
Jul 31, 2003
Jul 31, 2002
Jul 31, 2001
Jul 31, 2000
Jul 31, 1999
Jul 31, 1998
Jul 31, 1997
Jul 31, 1996

Enterprise Value Analysis

Price Change (Jul 2019 to Jul 2020)

The stock price has decreased from Jul 2019 to Jul 2020.
0.00%

Recent Volatility

The stock price has been relatively stable over the last 5 periods, indicating a lower risk profile.
0.00

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.00

Market Cap Change (Jul 2019 to Jul 2020)

The company's market capitalization has increased from Jul 2019 to Jul 2020.
+7.99%

Enterprise Value Change (Jul 2019 to Jul 2020)

The company's enterprise value has increased from Jul 2019 to Jul 2020, suggesting growth in the company's total economic value.
+28.89%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (25 periods), accounting for compounding effects.
17.27%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (25 periods), accounting for compounding effects.
23.89%